Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution.
Naohiro MatsunagaTomotaka SuzukiNozomi NishitarumizuYoko NakanishiAki KondoYukiyasu KatoToru EbinaYoshiaki MarumoTomoyuki NakamuraTakahiro NakashimaShiori KinoshitaTomoko NaritaMasaki RiShigeru KusumotoHirokazu KomatsuShinsuke IidaPublished in: Clinical lymphoma, myeloma & leukemia (2024)
This study provides an overview of the clinical impact of CMV reactivation in patients with PCD treated with anti-CD38 mAb-containing regimens.